CMS proposed rule addresses eCoin reimbursement for urge urinary incontinence
The rule includes a proposed unadjusted national average payment rate of US$21,376.53 for the device in 2024.
The rule includes a proposed unadjusted national average payment rate of US$21,376.53 for the device in 2024.
Urology Times® delivers analysis, perspectives, and practical advice about current health policy issues, clinical advances, and business challenges to urologists and allied health professionals. Each…
“So I think these findings overall are reassuring and support the use of neuromodulation in this population,” says Leo Dreyfuss, MD.
“Our results demonstrated that treatment with [the] Optilume BPH procedure resulted in significant symptom relief while still preserving erectile and ejaculatory function,” said Olivia Copelan,…
The dose escalation/dose expansion study is evaluating the safety and efficacy of AB-2100 in patients with ccRCC who either came back or did not improve…
“The association of lower testosterone concentrations with higher all-cause mortality was present irrespective of luteinizing hormone concentrations, indicating that low testosterone was the main factor,”…
“Also, the technique lends itself really nicely to these, what we call posterior ball-valve tumors, which are these tumors that sit behind the renal hilum,…
“The 2018 AUA guidelines for testosterone therapy that were co-chaired by Dr. John P. Mulhall say that we have an absence or a paucity of…
“The biggest take home point is that patients with node-positive disease at the time of radical prostatectomy are a heterogeneous group of patients,” says Daniel…
The Contouring Assistant now marks Profound Medical’s second FDA-cleared TULSA-AI module.
Urinary symptoms were not significantly improved from local estrogen use in most studies, though an improvement in vaginal symptoms was observed.